| Telik, Inc. |
The Rosen Law Firm has filed a class action lawsuit on behalf of investors that purchased TELIK stock from March 27, 2003 though June 4, 2007. The complaint alleges that TELIK concealed important negative information about TELCYTAs safety and efficacy, including recent Phase III trials showing that patients receiving Telcyta died much sooner than those receiving the standard treatment, raising doubts as to Telcytas safety. If you would like to join the TELIK class action as a plaintiff. please click on the link to the right and complete an online certification or you can print the form and fax it to us. |
| For more Information | |
 Case Summary
|
|
|
Press Release
|
|
 Read the Complaint
|
|
|